Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval

Global medical device company Nevro Corp has received US Food and Drug Administration (FDA) approval for the Senza HFX iQ spinal cord stimulation (SCS) system for the treatment of long-term or chronic pain.